SymPhysis Medical, founded in 2018, is a medical technology company focused on developing innovative solutions for the treatment of chronic diseases, with a strong emphasis on improving patient experience and quality of life. The company’s emerging technology, releaze, is a novel drainage system designed to treat malignant pleural effusion (MPE), a common and debilitating complication of late-stage cancers. MPE affects up to 15% of cancer patients and can cause severe shortness of breath and chest pain. By prioritizing patient-centered design, SymPhysis Medical aims to deliver more effective, comfortable, and accessible treatment options for individuals living with chronic and life-limiting conditions.